Spots Global Cancer Trial Database for breast cancer stage iv
Every month we try and update this database with for breast cancer stage iv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study. | NCT04852081 | Breast Cancer S... | Palbociclib Ribociclib Abemaciclib Letrozole Anastrozole Tamoxifen Fulvestrant Exemestane Alpelisib | 18 Years - | Blokhin's Russian Cancer Research Center | |
| A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer | NCT06075810 | Breast Cancer Breast Neoplasm Breast Cancer S... | MBQ-167 | 21 Years - | MBQ Pharma | |
| The Benefit of Surgery in Stage IV of Breast Cancer | NCT04697043 | Breast Cancer S... | Systemic therap... | 18 Years - 90 Years | Tehran University of Medical Sciences | |
| A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer | NCT03045289 | Metastatic Brea... Breast Cancer S... | Plant-Based Die... | 18 Years - | University of Rochester | |
| The Benefit of Surgery in Stage IV of Breast Cancer | NCT04697043 | Breast Cancer S... | Systemic therap... | 18 Years - 90 Years | Tehran University of Medical Sciences | |
| The Resistance and Immune Response to Palbociclib in Breast Cancer | NCT03401359 | Breast Cancer S... | tissue biopsy, ... | - | Samsung Medical Center | |
| Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer | NCT03202446 | Breast Cancer S... Breast Cancer, ... Breast Cancer S... | 1% Glycated Chi... Photothermal La... Placebo Cyclophosphamid... Standard of Car... | 18 Years - | Eske Corporation S.A.C | |
| Sitravatinib in Metastatic Breast Cancer | NCT04123704 | Breast Cancer S... Triple Negative... Breast Neoplasm... Breast Cancer M... | Sitravatinib | 18 Years - | Baylor Breast Care Center | |
| Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer | NCT00393341 | Breast Cancer S... Breast Cancer S... Breast Cancer S... | Blood Draw | 18 Years - | Indiana University | |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy | NCT06268665 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Invasive Breast... Ovarian Cancer Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Breast Cancer S... Breast Cancer I... Breast Cancer, ... Breast Cancer, ... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Cancer, Breast Tumors, Breast Mammary Cancer Mammary Carcino... Breast Carcinom... Breast Neoplasm Malignant Breas... Malignant Tumor... Cancer of Ovary Ovary Cancer Ovary Neoplasm | Tart Cherry Jui... | 18 Years - | University of California, Davis | |
| A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer | NCT05054374 | Breast Cancer Breast Cancer S... HER2-negative B... Solid Carcinoma MEK1 Gene Mutat... MEK2 Gene Mutat... Metastatic Brea... | Mirdametinib Fulvestrant | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of Pembrolizumab and Cryoablation in People With Breast Cancer | NCT06246968 | Metastatic Brea... Breast Cancer Breast Cancer S... Triple Negative... Triple Negative... Metastatic Trip... Locally Advance... Locally Advance... | Pembrolizumab Cryoablation | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Self-Advocacy Serious Game in Advanced Cancer | NCT03339765 | Ovarian Cancer ... Ovarian Cancer ... Breast Cancer S... Cervical Cancer... Cervical Cancer... Cervical Cancer... Endometrial Can... Endometrial Can... Vulvar Cancer, ... Vulvar Cancer, ... Vaginal Cancer ... Vaginal Cancer ... Vaginal Cancer ... | Strong Together... | 18 Years - | University of Pittsburgh | |
| HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan | NCT06236269 | Breast Cancer S... | Sacituzumab Gov... | 18 Years - | SOLTI Breast Cancer Research Group | |
| Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib | NCT05625087 | Breast Cancer S... | Alpelisib Ribociclib | 18 Years - | UNICANCER | |
| The Resistance and Immune Response to Palbociclib in Breast Cancer | NCT03401359 | Breast Cancer S... | tissue biopsy, ... | - | Samsung Medical Center | |
| Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422) | NCT01127074 | Metastatic Brea... | KS24.22 cells | 18 Years - 80 Years | University Hospital Tuebingen | |
| Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells | NCT04628806 | Melanoma Stage ... Sarcoma Squamous Cell C... Pancreatic Canc... Prostate Cancer Breast Cancer S... | CTC isolation b... | 18 Years - | Charite University, Berlin, Germany | |
| RWD Study in HER2+ mBC Patients in Third-Line Therapy | NCT04566458 | Breast Cancer S... | No intervention | 18 Years - | Exactis Innovation | |
| Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer | NCT05377047 | Breast Cancer S... Oligometastatic... | SABR | 18 Years - | Vastra Gotaland Region | |
| Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer | NCT03324425 | Breast Cancer S... | Simvastatin 80m... | 18 Years - | Baylor Breast Care Center | |
| To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors | NCT03159585 | Liver Cancer St... Gastric Cancer ... Esophageal Canc... Bone and Soft T... Breast Cancer S... Bladder Carcino... Prostate Carcin... Thyroid Cancer ... Ovarian Cancer ... Solid Tumor | TAEST16001 | 18 Years - 75 Years | Zhujiang Hospital | |
| Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis | NCT05860907 | Breast Cancer S... | Huaier Granule | 18 Years - 75 Years | Fudan University | |
| Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases | NCT05866432 | Breast Cancer S... | Datopotamab der... | 18 Years - 100 Years | Medical University of Vienna | |
| HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan | NCT06236269 | Breast Cancer S... | Sacituzumab Gov... | 18 Years - | SOLTI Breast Cancer Research Group | |
| Sitravatinib in Metastatic Breast Cancer | NCT04123704 | Breast Cancer S... Triple Negative... Breast Neoplasm... Breast Cancer M... | Sitravatinib | 18 Years - | Baylor Breast Care Center | |
| Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases | NCT04752059 | Breast Cancer S... | Trastuzumab der... | 18 Years - 100 Years | Medical University of Vienna | |
| A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer | NCT06075810 | Breast Cancer Breast Neoplasm Breast Cancer S... | MBQ-167 | 21 Years - | MBQ Pharma | |
| Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells | NCT04628806 | Melanoma Stage ... Sarcoma Squamous Cell C... Pancreatic Canc... Prostate Cancer Breast Cancer S... | CTC isolation b... | 18 Years - | Charite University, Berlin, Germany | |
| RWD Study in HER2+ mBC Patients in Third-Line Therapy | NCT04566458 | Breast Cancer S... | No intervention | 18 Years - | Exactis Innovation | |
| The Resistance and Immune Response to Palbociclib in Breast Cancer | NCT03401359 | Breast Cancer S... | tissue biopsy, ... | - | Samsung Medical Center | |
| Sitravatinib in Metastatic Breast Cancer | NCT04123704 | Breast Cancer S... Triple Negative... Breast Neoplasm... Breast Cancer M... | Sitravatinib | 18 Years - | Baylor Breast Care Center | |
| A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer | NCT05190770 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... | Triamcinolone A... Oleogel-S10 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer | NCT03045289 | Metastatic Brea... Breast Cancer S... | Plant-Based Die... | 18 Years - | University of Rochester | |
| Study of Dotatate Imaging in Breast Cancer | NCT05880394 | Breast Cancer S... | Gallium-68 DOTA... Copper-64 DOTAT... | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study. | NCT04852081 | Breast Cancer S... | Palbociclib Ribociclib Abemaciclib Letrozole Anastrozole Tamoxifen Fulvestrant Exemestane Alpelisib | 18 Years - | Blokhin's Russian Cancer Research Center | |
| Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients | NCT03870919 | Breast Cancer S... Radiotherapy Surgery | Palbociclib locoregional tr... | 18 Years - | UNICANCER | |
| Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity | NCT05036252 | Breast Cancer HER2-positive B... HER2-positive M... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Cardiotoxicity | Cardiopulmonary... Echocardiogram Echocardiograph... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy | NCT04133207 | Breast Cancer S... | 18 Years - | Hellenic Cooperative Oncology Group | ||
| Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study | NCT06234488 | Breast Cancer Breast Neoplasm... Breast Adenocar... Breast Cancer S... Breast Cancer S... Breast Cancer I... Breast Cancer i... | 18 Years - | Medical College of Wisconsin | ||
| Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. | NCT04896320 | Breast Cancer S... | Tucatinib | 18 Years - | Providence Health & Services | |
| Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer | NCT03202446 | Breast Cancer S... Breast Cancer, ... Breast Cancer S... | 1% Glycated Chi... Photothermal La... Placebo Cyclophosphamid... Standard of Car... | 18 Years - | Eske Corporation S.A.C | |
| A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients. | NCT04469127 | Breast Cancer S... | Lutetium-177-DO... | 18 Years - 80 Years | Advanced Imaging Projects, LLC | |
| Sitravatinib in Metastatic Breast Cancer | NCT04123704 | Breast Cancer S... Triple Negative... Breast Neoplasm... Breast Cancer M... | Sitravatinib | 18 Years - | Baylor Breast Care Center | |
| A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer | NCT02448771 | Breast Cancer S... Unresectable Lo... Metastatic Inva... | Palbociclib Bazedoxifene | 18 Years - | Dana-Farber Cancer Institute | |
| Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422) | NCT01127074 | Metastatic Brea... | KS24.22 cells | 18 Years - 80 Years | University Hospital Tuebingen | |
| Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer | NCT03202446 | Breast Cancer S... Breast Cancer, ... Breast Cancer S... | 1% Glycated Chi... Photothermal La... Placebo Cyclophosphamid... Standard of Car... | 18 Years - | Eske Corporation S.A.C | |
| A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer | NCT05190770 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... | Triamcinolone A... Oleogel-S10 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer | NCT03324425 | Breast Cancer S... | Simvastatin 80m... | 18 Years - | Baylor Breast Care Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
